JUBLCPL
Jubilant Agri and Consumer Products Limited
Jubilant Agri and Consumer Products Limited (JUBLCPL) financial statements and selected valuation metrics through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
jacpl.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
JACPL (Jubilant Agri and Consumer Products) makes performance polymers and chemicals (such as SBR latex), adhesives, phosphatic fertilisers and agri nutrients, selling to industrial customers, consumers and farmers in India and export markets.
Company snapshot
31stBy market cap
Ranked among 68 companies in Specialty Chemicals.
Segment mix
Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.
Largest segment: 71.9% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Agri Nutrients | 1.1% | 13 Cr | 5 Cr | — |
| P&K Fertilizers | 28.6% | 333 Cr | -3 Cr | — |
| Performance Polymers & Chemicals | 71.9% | 836 Cr | 126 Cr | — |
Shares add up to 102% because segment revenues are before inter-segment eliminations.
What we see
- ✓Debt-to-equity of 0.06x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 398 Cr | 398 Cr | 442 Cr | 513 Cr | 451 Cr | 485 Cr | 523 Cr |
| Operating expenses (approx.) | 363 Cr | 371 Cr | 380 Cr | 449 Cr | 412 Cr | 453 Cr | 455 Cr |
| EBITDA | 35 Cr | 27 Cr | 62 Cr | 64 Cr | 39 Cr | 33 Cr | 68 Cr |
| OPM % | 8.8% | 6.8% | 14.0% | 12.5% | 8.7% | 6.7% | 13.0% |
| Other income | -0.20 Cr | 0.54 Cr | 2 Cr | 0.09 Cr | 0.19 Cr | 2 Cr | 0.83 Cr |
| Interest | 3 Cr | 2 Cr | 2 Cr | 1 Cr | 2 Cr | 2 Cr | 2 Cr |
| Depreciation | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 5 Cr | 5 Cr | 5 Cr |
| Profit before tax | 28 Cr | 21 Cr | 58 Cr | 58 Cr | 29 Cr | 27 Cr | 62 Cr |
| Tax % | 23.1% | 24.6% | 24.2% | 27.6% | 25.8% | 25.0% | 25.1% |
| Net profit | 21 Cr | 16 Cr | 44 Cr | 42 Cr | 22 Cr | 20 Cr | 46 Cr |
| EPS (₹) | ₹14.16 | ₹10.64 | ₹29.29 | ₹28.06 | ₹14.20 | ₹13.09 | ₹30.43 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 1,561 Cr | 1,891 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 1,415 Cr | 1,695 Cr | Sign in free for the trailing twelve months |
| EBITDA | 146 Cr | 196 Cr | Sign in free for the trailing twelve months |
| OPM % | 9.3% | 10.4% | Sign in free for the trailing twelve months |
| Other income | 2 Cr | 4 Cr | Sign in free for the trailing twelve months |
| Interest | 13 Cr | 7 Cr | Sign in free for the trailing twelve months |
| Depreciation | 16 Cr | 18 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 117 Cr | 172 Cr | Sign in free for the trailing twelve months |
| Tax % | 25.2% | 25.7% | Sign in free for the trailing twelve months |
| Net profit | 88 Cr | 128 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹58.25 | ₹84.64 | Sign in free for the trailing twelve months |
| Dividend payout % | 0.0% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 15 Cr | 15 Cr |
| Reserves | 310 Cr | 445 Cr |
| Borrowings | 56 Cr | 28 Cr |
| Other liabilities | 354 Cr | 448 Cr |
| Total liabilities | 735 Cr | 935 Cr |
| Fixed assets (net) | 180 Cr | 198 Cr |
| CWIP | 19 Cr | 27 Cr |
| Investments | 0.07 Cr | 0.06 Cr |
| Loans & advances | 0.11 Cr | 0.19 Cr |
| Inventories | 191 Cr | 215 Cr |
| Trade receivables | 287 Cr | 409 Cr |
| Cash & bank | 6 Cr | 6 Cr |
| Other assets | 52 Cr | 81 Cr |
| Total assets | 735 Cr | 935 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operating activity | 129 Cr | 75 Cr |
| Cash from investing | -35 Cr | -39 Cr |
| Cash from financing | -104 Cr | -36 Cr |
| Net cash flow | -9 Cr | -0.24 Cr |
| Free cash flow (OCF − Capex) | 94 Cr | 35 Cr |
Ratios
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | 34.3% | 36.6% |
| ROE % | 27.0% | 27.8% |
| Debtor days | 67 | 79 |
| Inventory days | 88 | 85 |
| Days payable | 76 | 84 |
| Cash conversion cycle | 80 | 80 |
| OCF / EBITDA % | 88.8% | 38.2% |
| Debt / equity | 0.17 | 0.06 |
| Current ratio | 1.46 | 1.63 |
| Net debt / EBITDA | 0.34 | 0.11 |